ASAKE Biotechnology, LLC, founded by three investigators from Ohio University's Institute for Molecular Medicine and Aging (formerly Edison Biotechnology Institute), researches and develops novel health therapeutics utilizing natural resources. They specialize in biosynthetic technology and synthetic chemistry as well as emerging technologies including Proteolysis Targeting Chimeras (PROTAC). Their research centers on infectious diseases, diabetes, and cancer.
Contact:
asakebiotech@gmail.com
asakebiotech.com